Medication adherence: Factors influencing compliance with prescribed medication plans

Case Manager

Volumn 16, Issue 2, 2005, Pages 47-51

  Vlasnik, Jon J ^a   Aliotta, Sherry L ^b   DeLor, Bonnie ^c  

^a PFIZER INC   (United States)

^b SA Squared Inc   (United States)

^c PFIZER

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ASTHMA; COMORBIDITY; COST OF ILLNESS; DISEASE SEVERITY; ENVIRONMENT; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT INFORMATION; PRESCRIPTION; REVIEW; SUPPORT GROUP; WORLD HEALTH ORGANIZATION;

EID: 16844365330     PISSN: 10619259     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.casemgr.2005.01.009     Document Type: Article

References (52)

1. Miller NH, Hill M, Kottke T, Ockene IS. Expert Panel on Compliance. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 95:1997;1085-1090
2. Coons SJ. Medication compliance: the search for answers continues. Clin Ther. 23:2001;1294. 5
3. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a 6 year follow up study. Heart. 88:2002;229-233
4. Kopjar B, Sales AE, Pineros SL, Sun H, Li YF, Hedeen AN. Adherence with statin therapy in secondary prevention of coronary heart disease in Veterans Administration male population. Am J Cardiol. 92:2003;1106. 8
5. World Health Organization. Adherence to long-term therapies: evidence for action. 2003;World Health Organization, Geneva (Switzerland)
6. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 25:2003;2958-2971
7. Kennedy S, Stone A, Rachelefsky G. Factors associated with emergency department use in asthma: acute care interventions improving chronic disease outcomes. Ann Allergy Asthma Immunol. 90:2003;45-50
8. Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease. Clin Ther. 22:2000;452-469
9. Global Initiative for Asthma. 2002. Available at: http://www.ginasthma. com. Accessed Jan 20, 2005.
10. Knapp M, King D, Pugner K, Lapuerta P. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry. 184:2004;509-516
11. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 4:2004;191. 5
12. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther. 26:2001;331. 2
13. Podell RN, Gary LR. Compliance: a problem in medical management. Am Fam Physician. 13:1976;74-80
14. Zimmerman GL, Olsen CG, Bosworth MF. A "stages of change" approach to helping patients change behavior. Am Fam Physician. 61:2000;1409-1416
15. TEC Assessment Program. Special report: interventions to improve patient adherence with medications for chronic cardiovascular disorders. 2003;Blue Cross and Blue Shield Association, Chicago
16. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol. 109:(6 Suppl):2002;S554. 9
17. Wilson JF. The crucial link between literacy and health. Ann Intern Med. 139:2003;875. 8
18. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 29:(1 Suppl):2002;S2-S10
19. Coleman VR. Physician behaviour and compliance. J Hypertens Suppl. 3:1985;S69-S71
20. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 36:1998;1138-1161
21. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 38:2004;303-312
22. Lasater L, Mehler PS. The illiterate patient: screening and management. Hosp Pract. 33:1998;163-165. 169-70
23. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 40:2000;475-485
24. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol. 47:1992;1102-1114
25. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 31:(3 Suppl):2002;S123. 7
26. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am. 73:1989;1551-1563
27. Cline CMJ, Björck-Linné AK, Israelsson BYA, Willenheimer RB, Erhardt LR. Noncompliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail. 1:1999;145. 9
28. Barat I, Andreasen F, Damsgaard EMS. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 51:2001;615-622
29. California State Board of Pharmacy. Health notes: drug therapy considerations in older adults. 2003;17-18 California State Board of Pharmacy, Sacramento
30. Neff JA, Zule WA. Predictive validity of a measure of treatment readiness for out-of-treatment drug users: enhancing prediction beyond demographic and drug history variables. Am J Drug Alcohol Abuse. 28:2002;147-169
31. Divertie V. Strategies to promote medication adherence in children with asthma. MCN Am J Matern Child Nurs. 27:2002;10-18
32. Steele RG, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev. 6:2003;17-30
33. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 71:1993;3441. 9
34. Zilberman ML, Tavares H, Blume SB, et al., Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry. 48:2003;5-13
35. Kushel MB, Vittinghoff E, Haas JS. Factors associated with the health care utilization of homeless persons. JAMA. 285:2001;200. 6
36. Carter S, Taylor D, Levenson R. A question of choice - compliance in medicine taking: a preliminary review. 2004;73 Medicines Partnership, London
37. de Groot M, Welch G, Buckland GT III, Fergus M, Ruggiero L, Chipkin SR. Cultural orientation and diabetes self-care in low-income African Americans with type 2 diabetes mellitus. Ethn Dis. 13:2003;6-14
38. Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc. 91:1999;439-446
39. Collins KS, Tenney K, Hughes DL. Quality of health care for African Americans: findings from the Commonwealth Fund 2001 Health Care Quality Survey. Available at: www.cmwf.org. Accessed Jan 20, 2005.
40. Auslander WF, Thompson S, Dreitzer D, White NH, Santiago JV. Disparity in glycemic control and adherence between African-American and Caucasian youths with diabetes: family and community contexts. Diabetes Care. 20:1997;1569-1575
41. Charles H, Good CB, Hanusa BH, Chang C-CH, Whittle J. Racial differences in adherence to cardiac medications. J Natl Med Assoc. 95:2003;17-27
42. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 27:2001;251. 9
43. Opolka JL, Rascati KL, Brown CM, Gibson PJ. Role of ethnicity in predicting antipsychotic medication adherence. Ann Pharmacother. 37:2003;625-630
44. Francis CK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med. 91:(1A Suppl):1991;29-36S
45. Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care. 15:2003;217-230
46. Risser AL, Mazur LJ. Use of folk remedies in a Hispanic population. Arch Pediatr Adolesc Med. 149:1995;978-981
47. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 133:2000;21-30
48. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 17:2002;756-765
49. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS. 17:2003;169-177
50. Nosé M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med. 33:2003;1149-1160
51. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 180:2002;104. 9
52. Cheever LW. Adherence to HIV therapies. Available at: http://hab.hrsa.gov/publications/chapter5/chapter5.htm. Accessed Jan 20, 2005.